Coronavirus (COVID-19): If you need information about asbestos safety during the coronavirus (COVID-19) pandemic, please see our page here. If you need any general coronavirus information please see the Australian Government website. Asbestos related diseases also affect the respiratory system, just like coronavirus. If you have health concerns call your doctor or call the coronavirus hotline (24/7) - 1800 020 080.

MicroRNA replacement: A novel therapeutic approach for malignant mesothelioma

Date created: Date modified: 22 Feb 2018

Asbestos Diseases Research Institute (ADRI)

A breakthrough discovery found that an entire family of gene regulators, called microRNAs, are lost in mesothelioma. As part of a Cancer Council NSW funded grant, Associate Professor Glen Reid from the Asbestos Diseases Research Institute and his research team, in collaboration with scientists at the biotech company EnGeneIC, are creating a new therapeutic drug for mesothelioma that mimics those microRNAs which are lost during the development of mesothelioma. Restoring the activity of these microRNAs stops the growth of the mesothelioma cells and makes the cancer cells more sensitive to chemotherapy. For more information, visit the Cancer Council NSW website or ADRI website.